Clinic
UPMC Western Maryland Corporation
UPMC Western Maryland Corporation was paid $3.91M by Medicaid between Jan 2018 and Dec 2022, across 38 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 71% of everything it billed.
33Billing provider infoUPMC WESTERN MARYLAND CORPORATION
FROSTBURG, MD 21532
FROSTBURG, MD 21532
33aNPI1952495079assigned 10/03/2006
33bProvider typeUrgent Care Clinic/Center
28Total paid$3.91M
24GClaims101,123
24DCodes billed38
24AFirst – last monthJan 2018 – Dec 2022
Compared with peers
Next to other Urgent Care Clinic/Center providers in Maryland
Rank by total paid#26 of 114
Median peer was paid$654K
This provider vs. median6.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 200 | $12K | |
| 2019 | 523 | $17K | |
| 2020 | 28,643 | $852K | |
| 2021 | 42,952 | $1.25M | |
| 2022 | 28,805 | $1.78M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 71% | 46,767 | 42,097 | $2.76M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.6% | 5,424 | 4,817 | $297K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 6.2% | 16,293 | 14,595 | $244K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4.1% | 3,399 | 3,142 | $158K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.4% | 1,776 | 1,698 | $131K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.3% | 13,746 | 12,955 | $127K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 4,150 | 3,249 | $76K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.6% | 1,826 | 1,752 | $61K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,423 | 1,264 | $12K |
| 81002 | <1% | 3,216 | 2,945 | $11K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 269 | 237 | $6K |
| 73610 | <1% | 422 | 396 | $4K |
26 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 262 | $3K |
| 73630 | <1% | 313 | $3K | |
| 90682 | <1% | 63 | $2K | |
| 0001A | <1% | 70 | $1K | |
| 0011A | <1% | 74 | $1K | |
| 0012A | <1% | 62 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 230 | $1K |
| 73130 | <1% | 101 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 456 | $987.28 |
| 73110 | <1% | 92 | $837.33 | |
| 29125 | <1% | 26 | $808.68 | |
| 0002A | <1% | 33 | $708.00 | |
| 81025 | <1% | 166 | $615.36 | |
| 73140 | <1% | 50 | $554.60 | |
| 0064A | <1% | 31 | $520.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 49 | $424.84 |
| L4350 | Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf | <1% | 15 | $273.91 |
| L3260 | Surgical boot/shoe, each | <1% | 44 | $257.84 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 75 | $214.92 |
| A4565 | Slings | <1% | 39 | $144.13 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 16 | $101.02 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 49 | $88.60 |
| 99441 | <1% | 23 | $79.42 | |
| E0112 | Crutches underarm, wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 29 | $62.50 |
| 73562 | <1% | 12 | $22.71 | |
| 90715 | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUBLE, AMBER (SR. VP CFO)
Parent organizationUPMC WESTERN MARYLAND CORPORATION
| Provider | Location | Paid |
|---|---|---|
| UPMC Western Maryland Corporation | Cumberland, MD | $7.35M |
| UPMC Western Maryland Corporation | Cumberland, MD | $3.96M |
| UPMC Western Maryland Corporation | Cumberland, MD | $2.85M |
| UPMC Western Maryland Corporation | Cumberland, MD | $1.36M |
| UPMC Western Maryland Corporation | Cumberland, MD | $1.18M |
| UPMC Western Maryland Corporation | Cumberland, MD | $861K |
| UPMC Western Maryland Corporation | Cumberland, MD | $778K |
| UPMC Western Maryland Corporation | Ridgeley, WV | $65K |
| UPMC Western Maryland Corporation | Cumberland, MD | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.